BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Prideaux L, Kamm MA, De Cruz P, van Langenberg DR, Ng SC, Dotan I. Inflammatory bowel disease serology in Asia and the West. World J Gastroenterol 2013; 19(37): 6207-6213 [PMID: 24115818 DOI: 10.3748/wjg.v19.i37.6207]
URL: https://www.wjgnet.com/1007-9327/full/v19/i37/6207.htm
Number Citing Articles
1
Ravi Misra, Alan Askari, Omar Faiz, Naila Arebi. Colectomy Rates for Ulcerative Colitis Differ between Ethnic Groups: Results from a 15-Year Nationwide Cohort StudyCanadian Journal of Gastroenterology and Hepatology 2016; 2016: 1 doi: 10.1155/2016/8723949
2
J. Bonneau, C. Dumestre-Perard, M. Rinaudo-Gaujous, C. Genin, M. Sparrow, X. Roblin, S. Paul. Systematic review: New serological markers (anti-glycan, anti-GP2, anti-GM-CSF Ab) in the prediction of IBD patient outcomesAutoimmunity Reviews 2015; 14(3): 231 doi: 10.1016/j.autrev.2014.11.004
3
So Imakiire, Hidetoshi Takedatsu, Keiichi Mitsuyama, Hideto Sakisaka, Kozo Tsuruta, Masaru Morita, Nobuaki Kuno, Koichi Abe, Sadahiro Funakoshi, Hideki Ishibashi, Shinichiro Yoshioka, Takuji Torimura, Fumihito Hirai. Role of Serum Proteinase 3 Antineutrophil Cytoplasmic Antibodies in the Diagnosis, Evaluation of Disease Severity, and Clinical Course of Ulcerative ColitisGut and Liver 2022; 16(1): 92 doi: 10.5009/gnl210211
4
Guang-liang Chen, Juan Wang, Bao-zhen Li, Li-mei Li, Han-you Mo, Shuang Ye. Cutaneous Vasculitis, Interstitial Pneumonia with Crazy-Paving Appearance, and Positive pANCA in a Patient with Severe Crohn’s DiseaseCase Reports in Gastrointestinal Medicine 2014; 2014: 1 doi: 10.1155/2014/485714
5
Shulan Zhang, Ziyan Wu, Jing Luo, Xuefeng Ding, Chaojun Hu, Ping Li, Chuiwen Deng, Fengchun Zhang, Jiaming Qian, Yongzhe Li. Diagnostic Potential of Zymogen Granule Glycoprotein 2 Antibodies as Serologic Biomarkers in Chinese Patients With Crohn DiseaseMedicine 2015; 94(42): e1654 doi: 10.1097/MD.0000000000001654
6
Punyanganie de Silva, Joshua Korzenik. The Changing Epidemiology of Inflammatory Bowel Disease: Identifying New High-risk PopulationsClinical Gastroenterology and Hepatology 2015; 13(4): 690 doi: 10.1016/j.cgh.2014.11.022
7
Hironobu Takedomi, Motohiro Esaki. Usefulness of Biomarkers in the Management of Ulcerative ColitisNippon Daicho Komonbyo Gakkai Zasshi 2023; 76(10): 559 doi: 10.3862/jcoloproctology.76.559
8
Zhilong Xiao, Zhimin Pei, Min Yuan, Xueli Li, Shenjian Chen, Lijun Xu. Risk of Stroke in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysisJournal of Stroke and Cerebrovascular Diseases 2015; 24(12): 2774 doi: 10.1016/j.jstrokecerebrovasdis.2015.08.008
9
M. V. Kruchinina, I. O. Svetlova, M. F. Osipenko, N. V. Abaltusova, A. A. Gromov, A. V. Borisova, E. V. Kruchinina. The significance of serum marker levels for assessing the status and prognosis of patients with inflammatory bowel diseaseExperimental and Clinical Gastroenterology 2023; (4): 121 doi: 10.31146/1682-8658-ecg-212-4-121-132
10
Philip K. Frykman, Deven C. Patel, Sungjin Kim, Zhi Cheng, Tomas Wester, Agneta Nordenskjöld, Akemi Kawaguchi, Thomas T. Hui, Peter F. Ehrlich, Anna L. Granström, Filip Benliyan. Inflammatory Bowel Disease Serological Immune Markers Anti‐Saccharomyces cerevisiae Mannan Antibodies and Outer Membrane Porin C are Potential Biomarkers for Hirschsprung‐associated EnterocolitisJournal of Pediatric Gastroenterology and Nutrition 2019; 69(2): 176 doi: 10.1097/MPG.0000000000002358
11
Shulan Zhang, Jing Luo, Ziyan Wu, Dirk Roggenbuck, Peter Schierack, Dirk Reinhold, Ji Li, Xiaofeng Zeng, Fengchun Zhang, Jiaming Qian, Yongzhe Li. Antibodies against glycoprotein 2 display diagnostic advantages over ASCA in distinguishing CD from intestinal tuberculosis and intestinal Behçet's diseaseClinical and Translational Gastroenterology 2018; 9(2): e133 doi: 10.1038/ctg.2018.1
12
Jen-Wei Chou, Hsiang-Chun Lai, Chia-Hsi Chang, Ken-Sheng Cheng, Chun-Lung Feng, Tsung-Wei Chen. Epidemiology and Clinical Outcomes of Inflammatory Bowel Disease: A Hospital-Based Study in Central TaiwanGastroenterology Research and Practice 2019; 2019: 1 doi: 10.1155/2019/4175923
13
Peng Chen, Gaoshi Zhou, Jingxia Lin, Li Li, Zhirong Zeng, Minhu Chen, Shenghong Zhang. Serum Biomarkers for Inflammatory Bowel DiseaseFrontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.00123
14
Idan Goren, Tali Sharar Fischler, Henit Yanai, Partha Pal, Bhargavi Adigopula, Sushmitha Pendyala, Girish Ganesh, Ravikanth Vishnubhotla, Keren Masha Rabinowitz, Efrat Shaham Barda, Durga Yadamreddy, Lihi Godny, Noam Peleg, Rupa Banerjee, Iris Dotan. Newly Diagnosed Crohn’s Disease Patients in India and Israel Display Distinct Presentations and Serological Markers: Insights from Prospective CohortsJournal of Clinical Medicine 2022; 11(23): 6899 doi: 10.3390/jcm11236899
15
Zhaoxiu Liu, Bo Shen. Overcoming difficulty in diagnosis and differential diagnosis of Crohn’s disease: the potential role of serological and genetic testsExpert Review of Molecular Diagnostics 2015; 15(9): 1133 doi: 10.1586/14737159.2015.1068121
16
Susree Roy, Suchandrima Ghosh, Mallica Banerjee, Sayantan Laha, Dipanjan Bhattacharjee, Rajib Sarkar, Sujay Ray, Arko Banerjee, Ranajoy Ghosh, Aniket Halder, Alakendu Ghosh, Raghunath Chatterjee, Simanti Datta, Gopal Krishna Dhali, Soma Banerjee. A combination of circulating microRNA-375-3p and chemokines CCL11, CXCL12, and G-CSF differentiate Crohn’s disease and intestinal tuberculosisScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-02383-z
17
Siu Lam, Tao Zuo, Martin Ho, Francis K. L. Chan, Paul K. S. Chan, Siew C. Ng. Review article: fungal alterations in inflammatory bowel diseasesAlimentary Pharmacology & Therapeutics 2019; 50(11-12): 1159 doi: 10.1111/apt.15523
18
Wei-I. Lee, Kavitha Subramaniam, Carolyn A. Hawkins, Katrina L. Randall. The significance of ANCA positivity in patients with inflammatory bowel diseasePathology 2019; 51(6): 634 doi: 10.1016/j.pathol.2019.07.002
19
Tsahi T. Lerman, Eytan Cohen, Ilan Krause. Infection and Autoimmunity2024; : 115 doi: 10.1016/B978-0-323-99130-8.00008-8